VF
RCKTW icon

Virtu Financial’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Virtu Financial’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,746
Closed – – 2183
2025
Q4 		$0 Buy
+18,746
New +$611 ﹤0.01% 2136
2025
Q3 		– Sell
-11,402
Closed – – 1974
2025
Q2 		$0 Sell
11,402
-7,228
-39% -$301 ﹤0.01% 1950
2025
Q1 		$1K Buy
+18,630
New +$1.21K ﹤0.01% 1271

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's RCKTW Position: Q1 2026 in Review

Virtu Financial sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q1 2026, closing a stake of 18,746 shares.

Virtu Financial first reported a position in RCKTW in Q1 2025 and held it in 3 quarters. The position peaked at $1K in Q1 2025. 10 funds tracked by Wall St. Rank hold RCKTW as of Q1 2026.

  • Virtu Financial reported no remaining Rocket Pharmaceuticals Warrant position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 18,746 Rocket Pharmaceuticals Warrant shares in Q1 2026.
  • Virtu Financial first reported a position in Rocket Pharmaceuticals Warrant in Q1 2025 and held it in 3 quarters.
  • Virtu Financial's Rocket Pharmaceuticals Warrant position peaked at $1K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.